<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="medicine, echoing their own health-belief models of care during conventional" exact="cancer" post="treatments. The role of the integrative physician is to"/>
 <result pre="female artist who was recently diagnosed with localized hormone receptor-positive" exact="breast cancer." post="Following lumpectomy and sentinel node dissection, she is scheduled"/>
 <result pre="cyclophosphamide, and paclitaxel (AC-T protocol). She is worried about developing" exact="peripheral neuropathy" post="and its impact on her ability to paint, and"/>
 <result pre="and paclitaxel (AC-T protocol). She is worried about developing peripheral" exact="neuropathy" post="and its impact on her ability to paint, and"/>
 <result pre="medicine safety herb-drug interaction multidisciplinary approach 1. Introduction Patients with" exact="cancer" post="often seek out nonconventional treatments for the relief of"/>
 <result pre="outcomes associated with the use of herbal medicine during active" exact="cancer" post="care, making it difficult for them to help their"/>
 <result pre="other forms of complementary and integrative medicine within the supportive" exact="cancer" post="care setting. The prevalence and expectations of patients from"/>
 <result pre="(randomized, controlled trials) of herbal medicine in the treatment of" exact="cancer" post="is limited by a number of factors, which include"/>
 <result pre="controlled trial of 220 patients with locally advanced or metastatic" exact="pancreatic cancer," post="subcutaneous mistletoe injections were found to significantly increase survival"/>
 <result pre="in rigorous clinical trials to be effective in helping relieve" exact="cancer" post="treatment-related symptoms. These include ginger (Zingiber officinale) for chemotherapy-induced"/>
 <result pre="[15,18]. In a clinical study of patients with advanced non-small-cell" exact="lung cancer" post="undergoing treatment with vinorelbine and cisplatin, the use of"/>
 <result pre="In a clinical study of patients with advanced non-small-cell lung" exact="cancer" post="undergoing treatment with vinorelbine and cisplatin, the use of"/>
 <result pre="the CMF protocol (cyclophosphamide, methotrexate and fluorouracil) in patients with" exact="breast cancer" post="[20] and the FOLFOX regimen (fluorouracil, folinic acid and"/>
 <result pre="CMF protocol (cyclophosphamide, methotrexate and fluorouracil) in patients with breast" exact="cancer" post="[20] and the FOLFOX regimen (fluorouracil, folinic acid and"/>
 <result pre="folinic acid and oxaliplatin) in patients with gastric [21] and" exact="colorectal cancer" post="[22] 4. Safety of Herbal Medicine Use in Oncology"/>
 <result pre="acid and oxaliplatin) in patients with gastric [21] and colorectal" exact="cancer" post="[22] 4. Safety of Herbal Medicine Use in Oncology"/>
 <result pre="the product is still being sold as a cure for" exact="cancer" post="on the internet. 4.3. Herbâ€&quot;Drug Interactions The potential for"/>
 <result pre="potential for a herbal compound to negatively interact with conventional" exact="cancer" post="treatments is considered a major concern among many oncologists,"/>
 <result pre="have been shown to reduce glucose levels and complications of" exact="diabetes mellitus" post="[36]. However, medicinal mushrooms such as reishi (Ganoderma lucidum)"/>
 <result pre="(Ganoderma lucidum) and maitake (Grifola fondosa) have been associated with" exact="hypoglycemia" post="in patients treated with antidiabetic drugs [37,38]. Herbal products"/>
 <result pre="is the herb Ephedra foemina (â€œAlandaâ€�), a herbal treatment for" exact="cancer" post="which has become popular among the Arab-speaking population of"/>
 <result pre="used to test the cytotoxic activity of Alanda on two" exact="breast cancer" post="cell lines (MDA-MB231 and SKBR3). While no anticancer activity"/>
 <result pre="to test the cytotoxic activity of Alanda on two breast" exact="cancer" post="cell lines (MDA-MB231 and SKBR3). While no anticancer activity"/>
 <result pre="detected, it was shown that the addition of Alanda to" exact="cancer" post="cells in the presence of the chemotherapy agents carboplatin"/>
 <result pre="factors of 2 and 4 in the MDA-MB231 and SKBR3" exact="breast cancer" post="cell lines, respectively [27].Other herbs such as such as"/>
 <result pre="of 2 and 4 in the MDA-MB231 and SKBR3 breast" exact="cancer" post="cell lines, respectively [27].Other herbs such as such as"/>
 <result pre="indicus) have been shown to have significant cytostatic effects on" exact="cancer" post="cell lines [39,40], though their impact on conventional cytostatic"/>
 <result pre="in drug metabolism may also have a negative effect on" exact="cancer" post="treatment. An example of this is the drug tamoxifen"/>
 <result pre="antagonist which is the mainstay of treatment for hormone receptor-positive" exact="breast cancer." post="Tamoxifen is metabolized primarily in the liver by the"/>
 <result pre="supplement was found to reduce endoxifen levels in patients with" exact="breast cancer," post="through inhibition of the second-pass metabolism enzyme UGT [49]."/>
 <result pre="by the enzymes CYP3A4 and CYP3A5 in patients with non-small-cell" exact="lung cancer" post="[56]. Another example is the green tea component epigallocatechin-3-gallate"/>
 <result pre="the enzymes CYP3A4 and CYP3A5 in patients with non-small-cell lung" exact="cancer" post="[56]. Another example is the green tea component epigallocatechin-3-gallate"/>
 <result pre="Yet, in a randomized, controlled crossover trial of patients with" exact="breast cancer" post="treated with tamoxifen, no difference was found in geometric"/>
 <result pre="in a randomized, controlled crossover trial of patients with breast" exact="cancer" post="treated with tamoxifen, no difference was found in geometric"/>
 <result pre="advise about the concomitant use of these products with standard" exact="cancer" post="treatments, despite 60% reporting a lack of confidence in"/>
 <result pre="safe environment. In a survey of 269 female patients with" exact="breast cancer" post="in Israel, 111 (41.3%) reported using herbal medicinal products"/>
 <result pre="environment. In a survey of 269 female patients with breast" exact="cancer" post="in Israel, 111 (41.3%) reported using herbal medicinal products"/>
 <result pre="use of herbal medicine by patients have been described. Many" exact="cancer" post="centers provide complementary medicine treatments as part of their"/>
 <result pre="the use of herbal medicinal products during and after active" exact="cancer" post="care, there needs to be effective communication among oncologists,"/>
 <result pre="of interest. References References 1.BoonH.S.OlatundeF.ZickS.M.Trends in complementary/alternative medicine use by" exact="breast cancer" post="survivors: Comparing survey data from 1998 and 2005BMC Womens"/>
 <result pre="interest. References References 1.BoonH.S.OlatundeF.ZickS.M.Trends in complementary/alternative medicine use by breast" exact="cancer" post="survivors: Comparing survey data from 1998 and 2005BMC Womens"/>
 <result pre="Altern. Complement. Med.20071355556210.1089/acm.2007.03-904017604560 3.SaibulN.ShariffZ.M.RahmatA.SulaimanS.YawY.H.Use of complementary and alternative medicine among" exact="breast cancer" post="survivorsAsian Pac. J. Cancer Prev.2012134081408610.7314/APJCP.2012.13.8.408123098520 4.EisenbergD.M.KesslerR.C.FosterC.NorlockF.E.CalkinsD.R.DelbancoT.L.Unconventional Medicine in the"/>
 <result pre="Complement. Med.20071355556210.1089/acm.2007.03-904017604560 3.SaibulN.ShariffZ.M.RahmatA.SulaimanS.YawY.H.Use of complementary and alternative medicine among breast" exact="cancer" post="survivorsAsian Pac. J. Cancer Prev.2012134081408610.7314/APJCP.2012.13.8.408123098520 4.EisenbergD.M.KesslerR.C.FosterC.NorlockF.E.CalkinsD.R.DelbancoT.L.Unconventional Medicine in the"/>
 <result pre="10.Ben-AryeE.SamuelsN.GoldsteinL.H.MutafogluK.OmranS.SchiffE.CharalambousH.DweikatT.GhrayebI.Bar-SelaG.et al.Potential risks associated with traditional herbal medicine use in" exact="cancer" post="care: A study of Middle Eastern oncology health care"/>
 <result pre="main constituents in comparison with ricin and purothionin on human" exact="cancer" post="cellsJ. Ethnopharmacol.201923610010710.1016/j.jep.2019.02.04730840914 15.TrÃ¶gerW.GalunD.ReifM.SchumannA.StankoviÄ‡N.MiliÄ‡eviÄ‡M.Viscum album [L.] extract therapy in patients"/>
 <result pre="18.SemiglasovV.F.StepulaV.V.DudovA.LehmacherW.MengsU.The standardized mistletoe extract PS76A2 improves QoL in patients with" exact="breast cancer" post="receiving adjuvant CMF chemotherapy: A randomised, placebo-controlled, double-blind, multicentre"/>
 <result pre="standardized mistletoe extract PS76A2 improves QoL in patients with breast" exact="cancer" post="receiving adjuvant CMF chemotherapy: A randomised, placebo-controlled, double-blind, multicentre"/>
 <result pre="CancerN. Engl. J. Med.198230620120610.1056/NEJM1982012830604037033783 34.McCuneJ.S.HatfieldA.J.BlackburnA.A.R.LeithP.O.LivingstonR.B.EllisG.K.Potential of chemotherapy?herb interactions in adult" exact="cancer" post="patientsSupport. Care Cancer20041245446210.1007/s00520-004-0598-114991387 35.SamuelsN.Herbal remedies and anticoagulant therapyThromb. Haemost.200593030710.1160/TH04-05-0285"/>
 <result pre="al.Influence of green tea consumption on endoxifen steady-state concentration in" exact="breast cancer" post="patients treated with tamoxifenBreast Cancer Res. Treat.202018410711310.1007/s10549-020-05829-632803636 58.BraunL.HarrisJ.KatrisP.CainM.DhillonH.KoczwaraB.OlverI.RobotinM.Clinical Oncology"/>
 <result pre="of green tea consumption on endoxifen steady-state concentration in breast" exact="cancer" post="patients treated with tamoxifenBreast Cancer Res. Treat.202018410711310.1007/s10549-020-05829-632803636 58.BraunL.HarrisJ.KatrisP.CainM.DhillonH.KoczwaraB.OlverI.RobotinM.Clinical Oncology"/>
 <result pre="statement on the use of complementary and alternative medicine by" exact="cancer" post="patientsAsia Pac. J. Clin. Oncol.20141028929610.1111/ajco.1222725244342 59.Ben-AryeE.SchiffE.SilbermannM.AgbaryaA.Bar-SelaG.Perceptions of Complementary Medicine"/>
 <result pre="Med.20171711710.1186/s12906-017-1899-528049463 66.De LemosM.L.Pharmacistâ€™s role in meeting the psychosocial needs of" exact="cancer" post="patients using complementary therapyPsychooncology20051420421010.1002/pon.83615386775 67.YaoD.HuH.HarnettJ.UngC.O.L.Integrating traditional Chinese medicines into"/>
 <result pre="expectationsJ. Cancer Res. Clin. Oncol.20171432267227310.1007/s00432-017-2471-x28667389 70.Ben-AryeE.SchiffE.ZollmanC.HeusserP.MountfordP.FrenkelM.Bar-SelaG.LavieO.Integrating complementary medicine in supportive" exact="cancer" post="care models across four continentsMed. Oncol.2013301710.1007/s12032-013-0511-1 71.DengG.Integrative cancer care"/>
 <result pre="in supportive cancer care models across four continentsMed. Oncol.2013301710.1007/s12032-013-0511-1 71.DengG.Integrative" exact="cancer" post="care in a US academic cancer centre: The Memorial"/>
 <result pre="four continentsMed. Oncol.2013301710.1007/s12032-013-0511-1 71.DengG.Integrative cancer care in a US academic" exact="cancer" post="centre: The Memorial Sloanâ€&quot;Kettering experienceCurr. Oncol.200815Suppl. S2s108.es68s108.es7110.3747/co.v15i0.276 72.FrenkelM.CohenL.PetersonN.PalmerJ.L.SwintK.BrueraE.Integrative Medicine"/>
</results>
